Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) — Capital Reinvestment Ratio
Latest as of March 2026:
0.02x
Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a Capital Reinvestment Ratio of 0.02x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$90.44 Million) in capital expenditures (NT$1.42 Million). See 1762 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
NT$90.44 Million
TWD
Capital Expenditures
NT$1.42 Million
TWD
Data as of
Mar 2026
Most recent filing
Chunghwa Chemical Synthesis & Biotech Co Ltd Capital Reinvestment Ratio (2008–2025)
This chart tracks Chunghwa Chemical Synthesis & Biotech Co Ltd's Capital Reinvestment Ratio across 17 annual periods.
Annual Capital Reinvestment Ratio for Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)
Year-by-year Capital Reinvestment Ratio for Chunghwa Chemical Synthesis & Biotech Co Ltd from 2008 to 2025. For live market cap and broader valuation context, see 1762 market cap.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | NT$142.61 Million | NT$62.33 Million | ▲ +95.2% |
| 2024 | 0.22x | NT$467.65 Million | NT$104.69 Million | ▼ -56.3% |
| 2022 | 0.51x | NT$733.78 Million | NT$376.18 Million | ▼ -72.3% |
| 2021 | 1.85x | NT$219.18 Million | NT$405.45 Million | ▲ +32.5% |
| 2020 | 1.40x | NT$138.24 Million | NT$192.98 Million | ▲ +226.1% |
| 2019 | 0.43x | NT$268.13 Million | NT$114.80 Million | ▲ +7.2% |
| 2018 | 0.40x | NT$234.66 Million | NT$93.73 Million | ▼ -92.1% |
| 2017 | 5.06x | NT$159.34 Million | NT$805.80 Million | ▲ +1050.6% |
| 2016 | 0.44x | NT$261.31 Million | NT$114.86 Million | ▼ -72.9% |
| 2015 | 1.62x | NT$79.70 Million | NT$129.28 Million | ▼ -74.5% |
| 2014 | 6.35x | NT$23.08 Million | NT$146.59 Million | ▲ +738.2% |
| 2013 | 0.76x | NT$145.24 Million | NT$110.04 Million | ▼ -73.3% |
| 2012 | 2.84x | NT$268.46 Million | NT$762.95 Million | ▲ +513.3% |
| 2011 | 0.46x | NT$144.84 Million | NT$67.12 Million | ▲ +148.0% |
| 2010 | 0.19x | NT$275.61 Million | NT$51.50 Million | ▲ +136.2% |
| 2009 | 0.08x | NT$462.07 Million | NT$36.55 Million | ▼ -85.8% |
| 2008 | 0.56x | NT$75.39 Million | NT$42.12 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow